Cervomed Inc (CRVO) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access CRVO Annual Balance Sheets →
Tracking balance sheet results across Cervomed Inc to Mar 31 2025 helps illustrate how Mar 31 2026's financial position has responded to changing business conditions.
Quarterly Report, GAAP in USD millions
ITEM
(Mar 31 2026)
(Dec 31 2025) (Sep 30 2025) (Jun 30 2025) (Mar 31 2025)
Assets
Cash & cash equivalent7.94
Marketable Securities, Current SH4.98
Cash & Short-term Investments11.00
Grants Receivable, Current0.00
Deferred Offering Costs DE0.49
Other Current Assets1.70
Total Current Assets15.11
Other Assets, Noncurrent0.00
Prepaid Expenses Deposits And Other Assets1.70
Total Assets15.11
Liabilities
Accounts Payable, Current AC2.27
Other Accrued Liabilities, Current0.00
Total Current Liabilities2.27
Total Long-term Debt0.00
Other liabilities, Noncurrent2.22
AccruedExpensesAndOtherCurrentLiabilities2.22
Total Liabilities4.50
Stockholders' Equity
Common Stock Value0.01
Additional Paid In Capital Common Stock116.27
Retained Earnings / Accumulated Deficit-105.66
Other Equity0.00
Common Stockholder's Equity10.62
Total Stockholder's Equity10.62
Liabilities & Stockholder's Equity15.11
4 historic quarters locked

Sign in to unlock the full Cervomed Inc balance sheet history.

About Cervomed Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001437749-26-026592

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.